Trials / Conditions / Open Angle Glaucoma or Ocular Hypertension

Open Angle Glaucoma or Ocular Hypertension

6 registered clinical trials studyying Open Angle Glaucoma or Ocular Hypertension.

Status	Trial	Sponsor	Phase
Completed	OPC-1085EL in the Treatment of Primary Open Angle Glaucoma or Ocular Hypertension in Chinese Subjects NCT05583474	Otsuka Beijing Research Institute	Phase 3
Completed	A Phase III Multinational Multicenter Investigator-Masked Randomized Active-Controlled Trial Comparing the Eff NCT04133311	Santen SAS	Phase 3
Completed	A Phase III Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution Compared With Latanoprost Op NCT02981446	Santen Pharmaceutical Co., Ltd.	Phase 3
Completed	A Long-term Study of DE-117 Ophthalmic Solution Monotherapy and Concomitant Use of DE-117 Ophthalmic Solution NCT02822729	Santen Pharmaceutical Co., Ltd.	Phase 3
Completed	Multi-center Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Subjects With Primary Op NCT01868126	Santen Inc.	Phase 2
Completed	DE-111 Ophthalmic Solution in Patients With Open Angle Glaucoma or Ocular Hypertension NCT01343082	Santen Pharmaceutical Co., Ltd.	Phase 3